By Hannah Nelson
March 06, 2023 – A new ONC report to Congress outlines the significant impact of the 21st Century Cures Act on health IT interoperability.
As of 2021, nearly all non-federal acute care…
![Interoperability and Price Transparency in the 21st Century Cures Act: A Payer’s Perspective [Sponsored]](https://i0.wp.com/www.mediformatica.com/wp-content/uploads/2023/03/interoperability-and-price-transparency-in-the-21st-century-cures-act-a-payers-perspective-sponsored.jpg?fit=600%2C337&ssl=1)
Although it was signed into law in 2016, portions of the 21st Century Cures Act, the provisions designed to support interoperability continue created the need for new rules by the Centers for Medicare and…
Continue Reading
As a health economist, researcher in evidence-based medicine, and consultant to biopharma executives, I am no stranger to data. We all want more of it, to make sense of it, and to use it…
Continue Reading
COVID-19 forced a spike in policy-makers’ interest and willingness to invest in public health; a spike that is unfortunately retreating to the old business as usual. (President Biden, in his State of the Union…
Continue Reading
On February 13, the government leaders thanked the Office of the National Coordinator for Health IT and six Qualified Health Information Networks (QHIN) for working to create a nationwide interoperability network under the 21st Century Cures Act. The ‘Network of Networks’
At the U.S. Department of Health and Human services, Secretary Xavier Becerra presented certificates of recognition to the CommonWell Health Alliance, eHealth Exchange, Epic TEFCA Interoperability Services, Health Gorilla, Kno2 and KONZA for moving into the pre-production testing process of the Trusted Exchange Framework and the Common Agreement.
With the framework, ONC and the Sequoia Project, TEFCA’s recognized coordinating entity, seek to establish…
The CDS Coalition is asking the U.S. Food and Drug Administration to pull back on its clinical decision support guidance in order to ensure that the agency better balances its regulatory oversight with the healthcare sector’s need for innovation, while comporting with the statutory language of the 21st Century Cures Act. ‘Flagrant’ disregard for Congressional law and intent
The coalition’s stakeholders – clinical decision support software developers, patient advocacy organizations, clinical societies, healthcare providers and healthcare payers – say the FDA’s guidance exceeds Congress’s statutory definitions of what is considered CDS and threatens to undermine lawmakers’ goals.
“The Office of the National Coordinator for…
